Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061200
Filing Date
2023-11-08
Accepted
2023-11-08 16:36:35
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xene-20230930.htm   iXBRL 10-Q 2955734
2 EX-31.1 xene-ex31_1.htm EX-31.1 17823
3 EX-31.2 xene-ex31_2.htm EX-31.2 17797
4 EX-32.1 xene-ex32_1.htm EX-32.1 12719
5 EX-32.2 xene-ex32_2.htm EX-32.2 12079
  Complete submission text file 0000950170-23-061200.txt   8355350

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xene-20230930_def.xml EX-101.DEF 100799
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xene-20230930_lab.xml EX-101.LAB 318327
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xene-20230930_pre.xml EX-101.PRE 219516
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xene-20230930_cal.xml EX-101.CAL 43123
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xene-20230930.xsd EX-101.SCH 40244
52 EXTRACTED XBRL INSTANCE DOCUMENT xene-20230930_htm.xml XML 1479678
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 231388561
SIC: 2834 Pharmaceutical Preparations